Future Market Insights presents pertinent insights and a revised forecast of the global 3D printed medical devices market in its published report titled ‘3D Printed Medical Devices Market”: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’. The global 3D printed medical devices market is expected to expand at a CAGR of 18.1% during the forecast period 2017–2027. Increasing prevalence of chronic diseases and rising awareness regarding personal care are major factors that are driving the growth of the 3D printed medical devices market.
With increasing popularity of 3D printing, medical devices manufacturers are particularly focused on innovations. Substantial need for individualized yet economical medical solutions is met through 3D printing. Complex features of integration such as hard and soft areas, solid and porous structures, multi-material and multi-color, which seemed to be difficult by implementing conventional manufacturing techniques, is made simpler through 3D printing. Patient-specific implants are being manufactured based on CT and MRI scans provided by surgeons, which results in reduction of the overall surgical cost. This has increased the popularity of 3D printed medical devices all around the world.
The global 3D printed medical devices market is segmented based on application, technology, material type, end user and region. On the basis of application, the market has been segmented into orthopedic Implants, dental implants and cranio-maxillofacial implants. Orthopaedic implants application segment accounted for a higher revenue share in global 3D printing devices as compared to others in application segment. Orthopaedic implants segment in the application category of the global 3D printed medical devices market was estimated to be valued at nearly US$ 170 Mn in 2017 and is slated to reach a valuation of nearly US$ 970 Mn in 2027, exhibiting a CAGR of 19.2% during the period of assessment.
Based on the material type, 3D printed medical devices market is segmented into metals and alloys, biomaterial inks and plastics. The biomaterial inks segment was estimated to be valued at nearly US$ 65 Mn in 2017 and is anticipated to reach a valuation of nearly US$ 400 Mn in 2027, displaying a CAGR of 20% during the period of forecast. Based on the end user, 3D printed medical devices market is segmented into hospitals, ambulatory surgical centres and diagnostic centres. Hospital end user segment accounts for higher demand for 3D printing devices as compared to other distribution channel segments such as ambulatory surgical centres and diagnostic centres, registering a CAGR of 18.7% over the forecast period.
On the basis of region, the global 3D printed medical devices market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East and Africa. Revenues in Western Europe are expected to grow at a CAGR of 18.6%, whereas Eastern Europe is anticipated to grow at 15.5% over the forecast period. The Western Europe 3D printed medical devices market was estimated to be valued at nearly US$ 65 Mn in 2017 and is slated to reach a value of nearly US$ 360 Mn in 2027. The Eastern Europe 3D printed medical devices market was estimated to be valued at nearly US$ 40 Mn in 2017 and is anticipated to reach a value of nearly US$ 160 Mn in 2027.
Some of the players in the global 3D printed medical devices market include 3D Systems, Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K. and Formlabs, Inc. among others. Key players are focusing on strengthening their position by establishing new facilities in North America region. Moreover, companies are targeting Asia-Pacific region and Europe by distribution agreements with local players. In order to increase their revenue, major players in the North America region are entering into agreements with hospitals and academic institutes.
Request Report [email protected] https://www.futuremarketinsights.com/reports/sample/rep-gb-1501SOURCE The Financial Consulting https://thefinancialconsulting.com/